US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 450.370
  • -0.860-0.19%
Close Nov 21 16:00 ET
  • 450.350
  • -0.0200.00%
Post 18:52 ET
115.98BMarket Cap-237036P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 4, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.69B
2.77B
+81.58M
Beat Est.
+8.33%
+11.61%
+3.03%
EPS
3.63
4.01
+0.38
Beat Est.
-8.55%
+1.01%
+10.45%
Analyst Rating
Buy

Nov 21, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 9 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.799B--
--2024/Q4-- / 2.782B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 2.799B--
--2024/Q4-- / 2.782B--
Nov 4, 20242024/Q32.772B / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 5 16:17 ET

  • Vertex Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 16:06 ET

  • Vertex Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:50 ET

  • Vertex Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 15 16:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Buy

    • Buy

      62.96%

    • Hold

      29.63%

    • Sell

      7.41%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Gene Editing
    Gene Editing
    Intraday+0.44%